Advertisement

Topics

ImmunoMolecular Therapeutics Announces Two Issued Patents for Small Molecule Therapies in Type 1 Diabetes and Celiac Disease

08:00 EST 6 Dec 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
ImmunoMolecular Therapeutics (IM Therapeutics), a company developing personalized small molecule therapies for the treatment of genetically defined autoimmune diseases, today announced the issuance of US Patent 9,629,848 coverin...

Other Sources for this Article

MacDougall Biomedical Communications
Amanda Houlihan, 781-235-3060
ahoulihan@macbiocom.com
or
Kari Watson, 781-235-3060
kwatson@macbiocom.com

NEXT ARTICLE

More From BioPortfolio on "ImmunoMolecular Therapeutics Announces Two Issued Patents for Small Molecule Therapies in Type 1 Diabetes and Celiac Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...